The Pharmacogene Variation Consortium (PharmVar) serves as a global repository
providing star (*) allele nomenclature for the polymorphic human CYP4F2 gene. CYP4F2 …

Hypertension is a major healthcare issue that afflicts one in every three adults worldwide
and contributes to cardiovascular diseases, morbidity and mortality. Bioactive lipids …

Background/objectives To investigate the associations between ophthalmic parameters,
CYP4F2 (rs2108622) and ABCA1 (rs1883025) polymorphisms and coronary artery disease …

Background Age‐related macular degeneration (AMD) is the leading cause of blindness in
the elderly individuals. The etiology of AMD includes environmental and genetic factors …

Objectives: The underlying molecular mechanisms of diabetic nephropathy have yet not
been investigated clearly. In this investigation, we aimed to identify key genes involved in …

Background Our study aimed to explore the potential association of CYP4F2 gene
polymorphisms with lung cancer (LC) risk. Methods The five variants in CYP4F2 were …

Re: "Association Between the CYP4F2 Gene rs1558139 and rs2108622 Polymorphisms
and Hypertension: A Meta-Analysis" by Geng et al. (Genet Test Mol Biomarkers 2019;23:342-347; …

capacity for drug resistance, and immunosuppressive abilities. Traditional methods used
both for research of cancer and its subsequent treatment have fallen short of being able to …

Cardiovascular diseases are known to be treated with anticoagulants lifelong. Warfarin is
one of the most commonly used medications for anticoagulation despite causing serious …

The underlying molecular mechanisms of diabetic nephropathy (DN) have yet not been
investigated clearly. In this investigation, we aimed to identify key genes involved in the …